TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Cost of Revenue (2023)

Updated

TFA Therapeutics' Cost of Revenue came in at $484,607 for FY2025, up 39.7% from $347,004 in FY2024.

Analysis

TFA Therapeutics (RAJAF) Cost of Revenue (2023) Analysis & Trends

Going back to FY2020, TFA Therapeutics' Cost of Revenue data covers 6 years.

  • Cost of Revenue has increased in each of the last three years, with a five-year compound annual growth rate of 64.2% (FY2020 to FY2025).
  • The FY2025 figure represents the highest annual Cost of Revenue since FY2021.
  • Per Business Quant, earlier years put Cost of Revenue at $347,004 in FY2024 (+198.8%), $116,146 in FY2023 (+744.9%), $13,746 in FY2022 (-98.7%) and $1.06 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Procter & Gamble 373.44 Bn 325.24 Bn 11.60 Bn 11.68 Bn
2 Colgate Palmolive 74.95 Bn 70.01 Bn 3.30 Bn 2.07 Bn
3 Estee Lauder Companies 39.37 Bn 27.45 Bn 2.74 Bn 890.00 Mn
4 Kenvue 37.58 Bn 33.19 Bn 2.30 Bn 1.65 Bn
5 Kimberly Clark 36.64 Bn 33.96 Bn 1.60 Bn 2.59 Bn
6 Church & Dwight 24.96 Bn 23.48 Bn 693.90 Mn 836.10 Mn
7 Clorox 10.45 Bn 8.89 Bn 804.00 Mn 1.14 Bn
8 e.l.f. Beauty 6.73 Bn 5.70 Bn 398.84 Mn 80.53 Mn
9 Reynolds Consumer Products 4.85 Bn 4.52 Bn 245.00 Mn 699.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 30,842.00
API Access

TFA Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RAJAF&period=max&api_key=YOUR_API_KEY